Thymosin Alpha-1 for Cancer: Immunotherapy Support
How Thymosin Alpha-1 supports cancer immunotherapy. T-cell activation, dendritic cell maturation, clinical trial data, and practical protocols.
Clinical Protocols
Moderate EvidenceTargeted immune enhancement through supplementation, lifestyle, and clinical interventions.
How Thymosin Alpha-1 supports cancer immunotherapy. T-cell activation, dendritic cell maturation, clinical trial data, and practical protocols.
Evidence-based Thymosin Alpha-1 dosing. Subcutaneous protocols for immune support, cancer adjunct, infection, and chronic disease applications.
A tiered protocol for immune support -- seasonal prevention, pre-travel preparation, and acute illness response. By Dr. Julian Douwes.